Nanoparticles‐based drug delivery strategies have been widely researched for cancer
therapy. However, most of them are expected to accumulate in tumor sites via the enhanced …

The long circulation time and targeting drug delivery at tumor sites are still the main
challenges of nanodrug delivery systems for antitumor activity. Herein, a cancer cell …

Conventional chemotherapy drugs such as paclitaxel (PTX) can effectively inhibit tumor
growth by killing the majority of the proliferating cancer cells; however, it also results in multi …

Further specific target-ability development of biodegradable nanocarriers is extremely
important to promote their security and efficiency in antitumor drug-delivery applications. In …

Purpose In order to prepare a biomimetic nano-carrier which has inflammatory chemotaxis,
homologous targeting and reduce immune clearance, for targeted chemotherapy of …

The cancer cell–specific targeting and controlled drug delivery at the cancer site still remain
the main challenges for anticancer therapy. A cancer cell membrane–camouflaged …

Purpose Conventional chemotherapy is hampered by the presence of breast cancer stem
cells (BCSCs). It is crucial to eradicating both the bulky breast cancer cells and BCSCs …

In this study, a dual-ligand polymer-lipid hybrid nanoparticle drug delivery vehicle comprised
of an anti-HER2/neu peptide (AHNP) mimic with a modified HIV-1 Tat (mTAT) was …

Drug-loaded nanoparticles have been widely researched in the antitumor. However, some
of them are unsatisfactory in the long blood circulation and controlled drug release. Red …

Tumor stem cells have emerged as the new targets for anti-cancer therapy, besides tumor
cells themselves. To eradicate both breast cancer cells and breast cancer stem cells which …